Decision of the EEA Joint Committee No 122/2024 of 12 June 2024 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2024/2447]

Official Journal EN of the European Union L series 2024/2447 3.10.2024 DECISION OF THE EEA JOINT COMMITTEE No 122/2024 of 12 June 2024 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2024/2447] THE EEA JOINT COMMITTEE, Having regard to the Agreement on the European Economic Area (“the EEA Agreement”), and in particular Article 98 thereof,

Whereas:

(1) Commission Implementing Regulation (EU) 2023/2713 of 5 December 2023designating European Union reference laboratories in the field of in vitro diagnostic medical devices(1)is to be incorporated into the EEA Agreement.

(2) Annex II to the EEA Agreement should therefore be amended accordingly,

HAS ADOPTED THIS DECISION:

Article 1 The following point is inserted after point 12c (Commission Implementing Regulation (EU) 2022/945) of Chapter XXX of

Annex II to the EEA Agreement: ‘12d. 32023 R 2713: Commission Implementing Regulation (EU) 2023/2713 of 5 December 2023 designating European Union reference laboratories in the field of in vitro diagnostic medical devices (OJ L, 2023/2713,

6.12.2023).’ Article 2 The text of Implementing Regulation (EU) 2023/2713 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic.

Article 3 This Decision shall enter into force on 13 June 2024, provided that all the notifications under Article 103(1) of the EEA Agreement have been made(*).

Article 4 This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union.

Done at Brussels, 12 June 2024.

For the EEA Joint Committee The President Nicolas VON LINGEN

(1) OJ L, 2023/2713, 6.12.2023. (*) No constitutional requirements indicated.

ELI: http://data.europa.eu/eli/dec/2024/2447/oj 1/1